Historical salary details - Dr. Garry E. Menzel, PhD, Independent Director, Black Diamond Therapeutics Inc
Dr. Garry E. Menzel, PhD is the Independent Director of Black Diamond Therapeutics Inc. They also hold 2 other positions in Stoke Therapeutics Inc and Adaptimmune Therapeutics Plc - ADR.
Dr. Garry E. Menzel, Phd
Independent Director
-
Gross Remuneration
-
Current Company
Black Diamond Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Black Diamond Therapeutics Inc | Independent Director | - | - |
| 2024 | Stoke Therapeutics Inc | Independent Director | - | - |
| 2024 | Adaptimmune Therapeutics Plc - ADR | Independent Director | - | - |
| 2023 | Stoke Therapeutics Inc | Independent Director | 199.3 K | -6.9 % |
| 2023 | Adaptimmune Therapeutics Plc - ADR | Independent Director | 117.3 K | - |
| 2023 | Black Diamond Therapeutics Inc | Independent Director | 75.3 K | -1.6 % |
| 2022 | Stoke Therapeutics Inc | Independent Director | 214.1 K | -35.9 % |
| 2022 | Black Diamond Therapeutics Inc | Independent Director | 76.6 K | -80.7 % |
| 2021 | Black Diamond Therapeutics Inc | Independent Director | 397.5 K | 622.8 % |
| 2021 | Stoke Therapeutics Inc | Independent Director | 334.0 K | -62.4 % |
| 2020 | Stoke Therapeutics Inc | Independent Director | 888.5 K | - |
| 2020 | Black Diamond Therapeutics Inc | Independent Director | 55 K | -66.2 % |
| 2019 | Black Diamond Therapeutics Inc | Independent Director | 162.5 K | - |